Back to results
US 2003/0224447 A1Published application
Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites
AssigneeRandox Laboratories Limited
InventorsRobert Ivan McConnell, Elouard Benchikh, Stephen Peter Fitzgerald, John Victor Lamont
Life of this patent
Estimating the term…
Abstract
The invention provides haptens, immunogens comprising such haptens coupled to an antigenicity-conferring carrier material, conjugates comprising such haptens bonded to a labelling agent as well as, antibodies raised against such immunogens and capable of binding with ketamine and its primary metabolite, norketamine.
Claims37
A hapten derivatised with a crosslinker at the N-position of norketamine.
Dependencies are inferred from the claim text.